Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
July 17, 2026Open Access

The Last Mile Is the Hardest: Vaccine Equity, Manufacturing Resilience, and India's One Health Model After Covid-19

View Full Paper
Ask AI
Bookmark
Share

Authors

HTHarish Guggila Saranya Tadimeti*

Discussion

Loading...

Member takes

Overview

Review examines vaccine access, manufacturing, and delivery in India post-COVID-19, suggesting improvements for equity.

Key Points

  • This review aims to analyze vaccine access and manufacturing challenges in India after COVID-19.
  • Literature synthesis from PubMed, Scopus, and Web of Science (2000–2025), focusing on 2019–2025.
  • Data sourced from institutional references like WHO, CEPI, and Gavi.
  • Analysis of topics including manufacturing, equity-financing, and vaccine hesitancy.
  • Identified vulnerabilities in vaccine manufacturing and distribution during the 2021 export pause.
  • Highlighted India's One Health model's role in controlling zoonoses through integrated manufacturing.
  • Pointed out challenges like financing and health-worker shortages affecting vaccine delivery.

Cite This Study

Harish Guggila Saranya Tadimeti* (2026) studied this question.

synapsesocial.com/papers/6a59c63fa58755010b471629https://doi.org/10.5281/zenodo.21367487
View Full Paper
Ask AI
Bookmark
Share